title: A tale of five opinions (at least).
authors.affiliation: Roche Products Ltd, Welwyn Garden City, Hertfordshire AL7 1TW, UK. simon.day@Roche.com
authors.forename: Simon
authors.initials: S
authors.lastname: Day
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control*; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D004335:Drug and Narcotic Control; D005260:Female; D005464:Fluorobenzenes / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D011743:Pyrimidines / Q000627:therapeutic use*; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium